Grants>Clinical Trials

James Ewing Foundation of the Society of Surgical Oncology and Susan G. Komen for the Cure 2013 Fall Clinical Investigator Award in Breast Cancer Research

Application deadline: Monday, July 8, 2013

Purpose: To promote patient-oriented research conducted by surgical oncologists in clinical and translational science.

Eligibility

Applicants must be surgical oncologists within 10 years of completion of training

Be full SSO members for at least 6 months prior to application submission to be eligible for the award

Applicants must commit to at least 25% effort for this award

Terms of the Award

The award will be funded for two years at $100,000 ($50,000 per year) beginning October 1, 2013.  The Award concludes September 30, 2015.

The award is given to the sponsoring institution and may be used for partial support of applicant’s salary, research fellows or staff support, tuition, travel(no more than $2,000 per year) and/or supplies. No additional funds are available for paying indirect costs.

A brief year-one progress report with a financial update will be required by September 30, 2014. The JEF reserves the right to withhold the second year of support in the event of unsatisfactory progress.

A final report (not to exceed 4 pages) will be required before September 30, 2015. This should include a summary of the project, abstracts and publications acknowledged as supported by this award, and a financial report. Any unexpended funds from the scholarship are to be reimbursed back to JEF.

A brief (up to 10 minutes) presentation of results will be required at the March 2-5, 2016, SSO Annual Cancer Symposium in Boston, MA. 

The James Ewing Foundation of the Society of Surgical Oncology requests a proposal in which the applicant plays a central role in the conduct of a specific clinical research project. This might include for example a leadership role in a clinical trial, in a prospective cancer outcomes study, or a translational research project related to a prospective clinical trial. The clinical research focus must be hypothesis-driven and must have a direct patient-oriented focus.

Clinical trials may be investigator-initiated, industry-driven or organized by a cooperative group. While the applicant need not be the principal investigator of the trial, nor the lead institutional investigator, the extent to which the applicant is involved in study design and conduct must be clearly articulated. Ideal applicants will be early to mid-career investigators with a track record of peer-reviewed research funding who are seeking additional extramural support to further clinical cancer research. Of note, this award is not intended to serve as a career development award for new investigators seeking to initiate their research careers. The track record of the applicant, scientific merit of the application, novelty and clinical impact of the anticipated results, and resources available to ensure completion of the study will comprise the review criteria.

Questions?

Contact the James Ewing Foundation of the Society of Surgical Oncology, Email:  jef@surgonc.org, or phone 847-427-1400, ext. 111, M-F, 8:30 a.m. - 4:30 p.m. (CT).Address:9525 W. Bryn Mawr Ave., Suite 870 Rosemont, Illinois  60018.  Web: www.surgonc.org

ISCTR-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship

sponsored by Dignity Health, St. John's Hospital

The purpose of the program is to recognize and provide financial support for research efforts by outstanding cardiovascular scholars. This scholarship is to encourage junior faculty in the early phases of their careers in the field of cardiology. The program is intended for a physician with a strong interest in developing a career in cardiovascular translational research.

One year of previous interventional cardiology training is required. The duration of the program is one year. The awardee will develop skills and expertise in translating basic biological and device concepts into clinical application.

Goal: The overall goal of the program is to provide the clinical scientist (a physician) with the necessary scientific background that does not exist in today's curriculum. The program will enable the awardee to expedite scientific discovery to clinical application, ultimately benefitting the patient and society by providing science earlier and decreasing the developmental costs related to new devices and/or novel biologic therapies.

The program will cover the topics of:

• Basic science

• Preclinical science

• Clinical science and trial design

• Regulatory pathways (FDA) for IND (investigational new drug application) and IDE (investigational new device exemption)

The emphasis will be on biologics (stem cell therapy and genomics) and cardiovascular device development.

Objectives: The fellow will:

• Develop the skills and knowledge to take a scientific concept to the bedside

• Gain substantial knowledge about the steps in cardiovascular translational research

• Understand product development related to devices or biologics 

• Learn about toxicology studies required on small and large animal models that serve for IND or IDE application 

• Understand the statistical design and analysis required for toxicology studies, and phase I, II, and III clinical trials 

• Learn about the regulatory pathways for and how to prepare an IND (Investigational Drug Application) and an IDE (Investigational Device Exemption)

• Understand fundraising, NIH grant application process, opportunities in the venture capital arena, and developing and maintaining relationships with industry

Eligibility: Applicants eligible for the award are those who:

• Have completed one year of previous interventional cardiology. 

• Are members or are eligible to become a member of the ACC and ISCTR

• Will spend the duration of the Scholarship at an institution that has the ability to perform translational research (conducts both preclinical and clinical research) and can administer the curriculum found here:

http://www.cardiosource.org/~/media/Files/ACC/Membership/awards/ISCTR%20Curriculum.ashx

The Award: The award will offer $60,000 of salary support to begin July 1, 2014 and run through June 30, 2015.

Funding Source: The ACCF is grateful to Dignity Health St. John’s Hospital for their financial support for this award.

Nomination Procedure: Criteria for selection includes qualifications, background, interests, and commitment of the applicant.

How to Apply: The submission site for applications will open this summer. Please stay tuned for more information.

Deadline: September 23, 2013

For more information: Email Julia Berman or call 800-253-4636, ext. 6648.

Request for Application: A-T Children's Project

Attention Researchers:

Request for Application (RFA) for March 1, 2013 and September 1, 2013

Seed funding is now available for innovative proposals that seek to identify and validate biomarkers of A-T disease progression and that can be used to monitor therapeutic efficacy in clinical trials.

Please note that investigator-initiated proposals are also welcome for the March 1 and September 1 grant submission deadlines; however priority will be given to proposals that address the above referenced RFA.

We welcome investigators to contact Cynthia Rothblum-Oviatt, PhD, our Science Coordinator, if help is needed forming collaborations and/or obtaining reagents for A-T/ATM research.

Cynthia Rothblum-Oviatt, PhD
Science Coordinator
A-T Children's Project
5300 W. Hillsboro Blvd., Suite 105
Coconut Creek, FL 33073
cynthia@atcp.org
Phone: 703-765-1223

Clinician-Scientist Development Three-Year Award in Parkinson's Disease

Co-sponsored by the American Brain Foundation and the Parkinson's Disease Foundation

Application Deadline: October 1, 2013

The American Brain Foundation, the foundation of the American Academy of Neurology, and the Parkinson’s Disease Foundation are pleased to announce a three-year Clinician-Scientist Development Award to support a clinician scientist’s research related to Parkinson’s Disease.

The three-year award will consist of an annual salary of $75,000 plus $5,000 in educational expenses, per year. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.

ELIGIBILITY

1. Must be a neurologist interested in an academic career in clinical research.* Applicants must hold an MD, DO, or equivalent clinical degree from an accredited institution, and must be licensed to practice medicine in the United States.

2. Applicants must have completed residency training but be less than seven years from completion of residency when funding begins.

3. There is no citizenship requirement; however, the individual applying for the award must be licensed to practice medicine in the United States at the time of application.

Clinical research is defined as ”patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological disease.

For More Information

Kristin Roehl

Grants Program Manager
kroehl@aan.com
(612) 928-6082

Clinician-Scientist Development Three-Year Award in Myasthenia Gravis and Related Disorders of the Neuromuscular Junction

Cosponsored by the American Brain Foundation and the Myasthenia Gravis Foundation of America

Application Deadline: October 1, 2013

The American Brain Foundation, the foundation of the American Academy of Neurology, and the Myasthenia Gravis Foundation of America are pleased to announce a three-year Clinician-Scientist Development Award to support a clinician scientist’s research related to myasthenia gravis. The award aims to recognize the importance of good clinical research and encourage young investigators in clinical studies.

The three-year award will consist of an annual salary of $75,000 plus $5,000 in educational expenses, per year.

Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation
award. Only direct costs will be funded by this award.

ELIGIBILITY

1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency, fellowship, or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.

For More Information

Kristin Roehl

Grants Program Manager
kroehl@aan.com
(612) 928-6082

Susan S. Spencer Clinical Research Training Fellowship in Epilepsy

Sponsored by the American Brain Foundation, the American Epilepsy Society, and the Epilepsy Foundation

Application Deadline: October 1, 2013

The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce a two-year fellowship to support clinical research training in the field of epilepsy. The fellowship is supported by the American Brain Foundation, the American Epilepsy Society, and the Epilepsy Foundation.

Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere.

Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award.

ELIGIBILITY

1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency, fellowship, or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.

For More Information

Kristin Roehl

Grants Program Manager
kroehl@aan.com
(612) 928-6082

Clinical Research Training Fellowship

Sponsored by the American Brain Foundation and the American Academy of Neurology

Application Deadline: October 1, 2013

The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce up to ten two-year fellowships to support clinical research training in the neurosciences. The fellowships are supported by the American Brain Foundation and the American Academy of Neurology.

Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere.

Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award.

ELIGIBILITY

1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.

For More Information

Kristin Roehl

Grants Program Manager
kroehl@aan.com
(612) 928-6082

Clinical Research Training Fellowship in the Neurological Application of Neurotoxins

Funded by the Allergan Foundation

Application Deadline: October 1, 2013

The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce two two-year fellowships to support clinical research training on the neurological application of neurotoxins towards the treatment of neurological conditions and patient care. These fellowships are funded by the Allergan Foundation.

Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere.

Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.

ELIGIBILITY

1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency, fellowship, or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.

For More Information

Kristin Roehl

Grants Program Manager
kroehl@aan.com
(612) 928-6082
 

Clinical Research Training Fellowship in Ataxia

Sponsored by the American Brain Foundation and the National Ataxia Foundation

Application Deadline: October 1, 2013

The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce a two-year fellowship to support clinical research training in the field of ataxia. The fellowship is supported by the American Brain Foundation and the National Ataxia Foundation. Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.

ELIGIBILITY

1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency, fellowship, or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.

For More Information

Kristin Roehl

Grants Program Manager
kroehl@aan.com
(612) 928-6082
 

Sepsis 2013 Travel Grants and Awards

Sepsis 2013: New Successes, New Challenges

Sepsis 2013 is the ISF’s 6th annual Symposium.  Sepsis 2013 will be held at the Royal Tulip Hotel, Aquarela do Brasil, Sao Conrado, Rio de Janeiro, Brazil.  We are expecting an audience of 400 delegates from around the world.  Past Symposia have attracted delegates from more than 40 countries.  The official language will be English.

Sepsis 2013 will feature presentations by international experts, who will cover the most important topics of sepsis, spanning the spectrum from cutting edge basic science research to clinical aspects and trials.

Sepsis 2013 is an excellent opportunity to become up-to-date on everything that currently is going on in the field of sepsis!  In addition, there will be ample possibilities to present own scientific work and to informally interact with ISF council members during poster sessions.

Sponsored by the International Sepsis Forum.  Co-sponsored by the Latin American Sepsis Institute (LASI) and the Associacao de Medicina Intensiva Brasileira (AMIB)

A limited amount of funds may be available for travel support.  Travel support will only be provided to those with accepted abstracts that have completed and submitted the appropriate documentation before 3 August 2013.  Focus will be on supporting candidates for poor resource” countries and on those who have been previous awardees.  The awards include registration and a travel grant towards the recipients’ travel costs.

Applications must be received by 3 August 2013; confirmations of travel grants will be made before 31 August 2013.

Applicants must have a confirmed VISA access to Brazil if required 45 days prior to the Symposium. If a VISA application is refused the award will be re-allocated.

There is an age limit for applicants of 35 years (ie born in 1978 or later). Please apply in writing to the secretariat (you may scan in the documents and send by email).

Applicants must provide the following: letter of application; a copy of the abstract; a short CV including a list of publications if any; a copy of your passport information page.

Submit application via email to the following:

Elaine Rinicker ISF Executive Director  Elaine@sepsisforum.org

Young Investigator’s Award

Available to authors of abstracts accepted who are less than 35 years and not in permanent employment. The award is available to clinicians, nurses, scientists and allied professions with an interest in Sepsis. The award is to encourage all younger researchers from all specialities to submit research and case histories with a sepsis connection.

Terms and Conditions for Young Investigator Awards

Applications to be made in writing by the Head of Department to the secretariat.

Applications to be made before 2 August 2013 (coinciding with the Abstract Submission deadline). Late applications will not be accepted.

Submit application via email to the following:

Elaine Rinicker ISF Executive Director  Elaine@sepsisforum.org